IHS Chemical Week

EnviroTech :: R&D

Nicholas Piramal to Spin Off R&D Unit

9:00 AM MDT | September 12, 2007 | Deepti Ramesh

Pharmaceutical company Nicholas Piramal India Ltd. (NPIL; Mumbai) says it plans to demerge its R&D unit, creating a separate, independent company focused on developing novel drugs, otherwise known as new chemical entities (NCE). The demerger will be in the form of a spin-off to shareholders. NPIL will have an 18% stake in the new company, and NPIL’s shareholders will hold the rest. A proposal for the demerger has been approved by the NPIL board, and awaits regulatory and other approvals. NPIL will transfer net assets worth about $24 million to the new...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa